Biotech companies in the United States by P/B ratio

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Biogen has the lowest figure of the 18 biotech companies in the United States ranked by P/B ratio, at 1.9, followed by Vaxcyte (3.5) and Neurocrine Biosciences (4.1). Figures as of 19 Nov 2026, 22:51 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
18
Lowest
Biogen1.9
Median
8.7
Combined market value
$734.9B
Countries
1
Not ranked
2no P/B ratio on file

Market values as of .

United States
All sectors
Biotech
USD
Clear filters
Biotech companies in the United States by P/B ratio
#CompanyP/B ↑Market capPriceToday1 yearPrice, 30 daysCountry
1BiogenBIIB · Health Care1.9$36.5B$247.13 1.70% down 49% up United States
2VaxcytePCVX · Health Care3.5$9.2B$58.36 0.27% down 23% up United States
3Neurocrine BiosciencesNBIX · Health Care4.1$15.8B$156.59 3.85% down 17% up United States
4RepligenRGEN · Health Care4.6$10.9B$170.29 1.38% down 12% up United States
5Bio-TechneTECH · Health Care5.3$11.4B$72.70 0.07% down 24% up United States
6Kymera TherapeuticsKYMR · Health Care6.3$10.2B$119.39 1.44% down 87% up United States
7Krystal BiotechKRYS · Health Care6.5$9.4B$315.82 0.15% up 54% up United States
8CG OncologyCGON · Health Care7.4$7.3B$81.90 2.38% up 97% up United States
9Twist BioscienceTWST · Health Care8.5$7.6B$111.62 4.07% down 346% up United States
10ExelixisEXEL · Health Care8.8$16.1B$65.83 3.60% down 63% up United States
11ImmunovantIMVT · Health Care10.2$6.7B$32.52 1.96% down 46% up United States
12ModernaMRNA · Health Care11.8$80.7B$199.33 1.29% up 780% up United States
13Revolution MedicinesRVMD · Health Care14.4$34.5B$159.43 0.24% down 129% up United States
14Gilead SciencesGILD · Health Care15.8$206.6B$166.53 1.45% down 35% up United States
15AmgenAMGN · Health Care16.5$237.4B$438.82 1.14% down 32% up United States
16Adaptive BiotechnologiesADPT · Health Care25.7$4.5B$28.05 1.44% down 74% up United States
17Scholar Rock HoldingSRRK · Health Care36.4$6.1B$50.37 4.94% up 26% up United States
18Kodiak SciencesKOD · Health Care499$6.4B$97.90 0.09% up 399% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. 2 companies have no P/B ratio on file and are not ranked here.

Questions and answers

Which biotech companies in the United States have the lowest P/B ratio?

Biogen (1.9), Vaxcyte (3.5) and Neurocrine Biosciences (4.1) have the lowest P/B ratio of the 18 biotech companies in the United States ranked here as of 19 Nov 2026, 22:51 UTC.

How many biotech companies in the United States are in this ranking?

18 are ranked by P/B ratio. 2 more have no P/B ratio on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 18 biotech companies in the United States ranked by P/B ratio have a combined market value of $734.9B as of 19 Nov 2026, 22:51 UTC.

What does ranking by P/B ratio measure?

Share price divided by book value per share: what the market pays for each dollar of shareholders' equity on the balance sheet.

Cite this page

Funkfolio, “Biotech companies in the United States by P/B ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=pb-ratio

Underlying data: Yahoo Finance; SEC EDGAR.